AAAAAA

   
Results: 1-9 |
Results: 9
AQUEOUS STABILITY OF SB-210661 - KINETICS AND PRIMARY DEGRADATION MECHANISMS OF AN N-HYDROXYUREA-CONTAINING 5-LIPOXYGENASE INHIBITOR
Authors: MCLOUGHLIN M KEARNEY AS PALEPU NR
Citation: M. Mcloughlin et al., AQUEOUS STABILITY OF SB-210661 - KINETICS AND PRIMARY DEGRADATION MECHANISMS OF AN N-HYDROXYUREA-CONTAINING 5-LIPOXYGENASE INHIBITOR, Journal of Pharmacy and Pharmacology, 50(2), 1998, pp. 127-132
INVESTIGATION OF NEW DEGRADATION PRODUCTS ARISING FROM THE ENCAPSULATION OF AN OIL-BASED SUSPENSION FORMULATION OF TOPOTECAN
Authors: PATEL K KEARNEY AS PALEPU NR
Citation: K. Patel et al., INVESTIGATION OF NEW DEGRADATION PRODUCTS ARISING FROM THE ENCAPSULATION OF AN OIL-BASED SUSPENSION FORMULATION OF TOPOTECAN, International journal of pharmaceutics, 151(1), 1997, pp. 7-13
PREFORMULATION STUDIES TO AID IN THE DEVELOPMENT OF A READY-TO-USE INJECTABLE SOLUTION OF THE ANTITUMOR AGENT, TOPOTECAN
Authors: KEARNEY AS PATEL K PALEPU NR
Citation: As. Kearney et al., PREFORMULATION STUDIES TO AID IN THE DEVELOPMENT OF A READY-TO-USE INJECTABLE SOLUTION OF THE ANTITUMOR AGENT, TOPOTECAN, International journal of pharmaceutics, 127(2), 1996, pp. 229-237
PRODRUGS AND TARGETED DRUG-DELIVERY
Authors: KEARNEY AS
Citation: As. Kearney, PRODRUGS AND TARGETED DRUG-DELIVERY, Advanced drug delivery reviews, 19(2), 1996, pp. 225-239
EFFECT OF POLYVINYLPYRROLIDONE ON THE CRYSTALLINITY AND DISSOLUTION RATE OF SOLID DISPERSIONS OF THE ANTIINFLAMMATORY CI-987
Authors: KEARNEY AS GABRIEL DL MEHTA SC RADEBAUGH GW
Citation: As. Kearney et al., EFFECT OF POLYVINYLPYRROLIDONE ON THE CRYSTALLINITY AND DISSOLUTION RATE OF SOLID DISPERSIONS OF THE ANTIINFLAMMATORY CI-987, International journal of pharmaceutics, 104(2), 1994, pp. 169-174
PREFORMULATION STUDIES TO AID IN THE DEVELOPMENT OF AN INJECTABLE FORMULATION OF PD-144872, A RADIOSENSITIZING ANTICANCER AGENT
Authors: KEARNEY AS MEHTA SC RADEBAUGH GW
Citation: As. Kearney et al., PREFORMULATION STUDIES TO AID IN THE DEVELOPMENT OF AN INJECTABLE FORMULATION OF PD-144872, A RADIOSENSITIZING ANTICANCER AGENT, International journal of pharmaceutics, 102(1-3), 1994, pp. 63-70
THE INTERCONVERSION KINETICS, EQUILIBRIUM, AND SOLUBILITIES OF THE LACTONE AND HYDROXYACID FORMS OF THE HMG-COA REDUCTASE INHIBITOR, CI-981
Authors: KEARNEY AS CRAWFORD LF MEHTA SC RADEBAUGH GW
Citation: As. Kearney et al., THE INTERCONVERSION KINETICS, EQUILIBRIUM, AND SOLUBILITIES OF THE LACTONE AND HYDROXYACID FORMS OF THE HMG-COA REDUCTASE INHIBITOR, CI-981, Pharmaceutical research, 10(10), 1993, pp. 1461-1465
THE EFFECT OF STRUCTURAL-CHANGES ON THE INTRAMOLECULAR DEGRADATION OFTHE DIPEPTOID CI-988
Authors: KEARNEY AS MEHTA SC RADEBAUGH GW
Citation: As. Kearney et al., THE EFFECT OF STRUCTURAL-CHANGES ON THE INTRAMOLECULAR DEGRADATION OFTHE DIPEPTOID CI-988, International journal of pharmaceutics, 92(1-3), 1993, pp. 63-70
THE ANOMALOUS HYDROLYTIC BEHAVIOR OF 1-PHENYLVINYL PHOSPHATE
Authors: KEARNEY AS STELLA VJ
Citation: As. Kearney et Vj. Stella, THE ANOMALOUS HYDROLYTIC BEHAVIOR OF 1-PHENYLVINYL PHOSPHATE, Pharmaceutical research, 9(3), 1992, pp. 378-384
Risultati: 1-9 |